Anticoagulant therapy during extracorporeal photopheresis (ECP) helps prevent clot formation in the circuit but requires careful monitoring to balance bleeding risks. Adjusting the anticoagulant dose based on patient-specific factors and coagulation tests is crucial for safety and efficacy.